Clinical implications of the results of recent atherothrombotic trials on patient management

被引：1

作者：

Betriu, Amadeo ^{[1
]}

机构：

[1] Hosp Clin Barcelona, Dept Cardiol, Hemodynam Unit, E-08036 Barcelona, Spain

来源：

EUROPEAN HEART JOURNAL SUPPLEMENTS | 2008年 / 10卷 / 0I期

关键词：

Acute coronary syndrome; Percutaneous coronary intervention; Atherothrombotic trials; Glycoprotein IIb/IIIa inhibitors; Heparin; Clopidogrel;

D O I：

10.1093/eurheartj/sun040

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Significant advances have been made over the last several years in the treatment of patients with acute coronary syndromes including the introduction and approval of new antithrombin and antiplatelet agents. Results from a number of studies have impacted treatment strategies of patients with and without percutaneous coronary intervention. The study design and results of five trials: OASIS-5 PCI, PCI-ACUITY, TRITON-TIMI-38, FINESSE, and CARESS-in-AMI will be reviewed, and implications for clinical practice presented.

引用

页码：30 / 32

页数：3

共 8 条

[1] Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161
[2] Immediate angioplasty versus standard therapy with rescue 3 angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial
Di Mario, Carlo
Dudek, Dariusz
Piscione, Federico
Mielecki, Waldemar
Savonitto, Stefano
Murena, Ernesto
Dimopoulos, Konstantinos
Manari, Antonio
Gaspardone, Achille
Ochala, Andrzej
Zmudka, Krzysztof
Bolognese, Leonardo
Steg, Philippe Gabriel
Flather, Marcus
[J]. LANCET, 2008, 371 (9612) : 559 - 568
[3] Facilitated PCI in patients with ST-elevation myocardial infarction
Ellis, Stephen G.
Tendera, Michal
de Belder, Mark A.
van Boven, Ad J.
Widimsky, Petr
Janssens, Luc
Andersen, H. R.
Betriu, Amadeo
Savonitto, Stefano
Adamus, Jerzy
Peruga, Jan Z.
Kosmider, Maciej
Katz, Olivier
Neunteufl, Thomas
Jorgova, Julia
Dorobantu, Maria
Grinfeld, Liliana
Armstrong, Paul
Brodie, Bruce R.
Herrmann, Howard C.
Montalescot, Gilles
Neumann, Franz-Josef
Effron, Mark B.
Barnathan, Elliot S.
Topol, Eric J.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (21) : 2205 - 2217
[4] The SYNERGY trial: Study design and rationale
Ferguson, JJ
Califf, RM
Antman, EM
Cohen, M
Grines, CL
Kereiakes, DJ
Langer, A
Mahaffey, KW
Nessel, CC
Rios-Nogales, L
[J]. AMERICAN HEART JOURNAL, 2002, 143 (06) : 952 - 960
[5] Efficacy and safety of fondaparinux versus Enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Results from the OASIS-5 trial
Mehta, Shamir R.
Granger, Christopher B.
Eikelboom, John W.
Bassand, Jean-Pierre
Wallentin, Lars
Faxon, David P.
Peters, Ron J. G.
Budaj, Andrzej
Afzal, Rizwan
Chrolavicius, Susan
Fox, Keith A. A.
Yusuf, Salim
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (18) : 1742 - 1751
[6] Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial
Stone, Gregg W.
White, Harvey D.
Ohman, E. Magnus
Bertrand, Michel E.
Lincoff, A. Michael
McLaurin, Brent T.
Cox, David A.
Pocock, Stuart J.
Ware, James H.
Feit, Frederick
Colombo, Antonio
Manoukian, Steven V.
Lonsky, Alexandra J.
Mehran, Roxana
Moses, Jeffrey W.
[J]. LANCET, 2007, 369 (9565) : 907 - 919
[7] WIDIMSKY P, 2008, EUR HEART J
[8] Prasugrel versus clopidogrel in patients with acute coronary syndromes
Wiviott, Stephen D.
Braunwald, Eugene
McCabe, Carolyn H.
Montalescot, Gilles
Ruzyllo, Witold
Gottlieb, Shmuel
Neumann, Franz-Joseph
Ardissino, Diego
De Servi, Stefano
Murphy, Sabina A.
Riesmeyer, Jeffrey
Weerakkody, Govinda
Gibson, C. Michael
Antman, Elliott M.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (20) : 2001 - 2015

← 1 →